Plasma Catecholamines, Thrombocyte Alpha 2- and Lymphocyte Beta 2-Adrenoceptor Densities in Hypertensive Patients with Low or Normal Plasma Renin Concentrations

The sympathetic nervous system is unique in the regulation of plasma renin, for it can stimulate or suppress renin release by activation of either renal beta- or alpha2-adreno ceptors. The authors studied plasma renin concentration (PRC), noradrenalin and adrenalin levels in plasma, and the densities of lymphocyte beta2-adrenoceptors and thrombocyte alpha2-adrenoceptors in 25 hypertensive patients with either normal (11-40 mU/L; n=9) or low PRC (0-10 mU/L; n=14). There were no differences in plasma cate cholamine levels and adrenoceptor densities between the two patient groups. A positive correlation (r=0.66; P < 0.005) between beta2-adrenoceptor density and PRC in the patient group with low PRC, and a negative correlation (r=-0.72; P < 0.01) between alpha2-adrenoceptor density and plasma renin in patients with normal PRC were found. They conclude that adrenoceptor densities on blood elements and plasma catecholamines do not differ in low and normal renin hypertension. The significant correlations between adrenoceptor densities and PRCs may indicate that adrenoceptors on blood elements mirror adrenoceptor densities in the kidney and that tonic suppression of renin release through alpha2-adrenoceptors is preserved in hypertensive patients with normal plasma renin levels.

[1]  A. Swaak,et al.  DISEASE-ACTIVITY OF SLE DURING DIALYSIS AND AFTER RENAL-TRANSPLANTATION , 1990 .

[2]  M. Bristow,et al.  Beta-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes? , 1989, European heart journal.

[3]  M. Michel,et al.  Alpha- and beta-adrenoceptors in hypertension. II. Platelet alpha 2- and lymphocyte beta 2-adrenoceptors in children of parents with essential hypertension. A model for the pathogenesis of the genetically determined hypertension. , 1989, Journal of cardiovascular pharmacology.

[4]  M. Michel,et al.  Decreased myometrial β‐adrenoceptors in women receiving β2‐adrenergic tocolytic therapy: Correlation with lymphocyte β‐adrenoceptors , 1989 .

[5]  P. D. de Leeuw,et al.  Alpha‐adrenoceptors and the kidney , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[6]  P. Cryer,et al.  Direct relationship between mononuclear leukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha- and beta-adrenergic receptors by the sympathochromaffin system in humans. , 1988, The Journal of clinical investigation.

[7]  M. Michel,et al.  Correlation between human myometrial and platelet alpha 2-adrenoceptor density. , 1988, European journal of pharmacology.

[8]  Jackson Ca,et al.  Arterial pressure and renal function in two-kidney, one clip Goldblatt hypertensive rats maintained on a high-salt intake. , 1986 .

[9]  M. Kuhar,et al.  Localization of beta adrenoceptor subtypes in rat kidney by light microscopic autoradiography. , 1985, The Journal of pharmacology and experimental therapeutics.

[10]  M. Feraudi,et al.  Electrochemical detection of catecholamines in urine and plasma after separation with HPLC. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[11]  B. Morris,et al.  Inhibitory by α-adrenoceptor agonists of renin release in vitro , 1979 .

[12]  J. Štěpán,et al.  Über das Vorkommen des Zirkoniums in einigen Organen des Meerschweinchens und des Menschen und seine Beeinflussung besonders durch Quecksilber , 1961 .

[13]  T. Philipp,et al.  Alpha- and beta-adrenoceptors in hypertension: molecular biology and pharmacological studies. , 1992, Pharmacology & toxicology.

[14]  M. Michel,et al.  Decreased myometrial beta-adrenoceptors in women receiving beta 2-adrenergic tocolytic therapy: correlation with lymphocyte beta-adrenoceptors. , 1989, Clinical pharmacology and therapeutics.

[15]  W. Pettinger Renal alpha 2-adrenergic receptors and hypertension. , 1987, Hypertension.

[16]  D. Goldstein,et al.  Plasma catecholamines and essential hypertension. An analytical review. , 1983, Hypertension.

[17]  B. Morris,et al.  Inhibition by alpha-adrenoceptor agonists of renin release in vitro. , 1979, European journal of pharmacology.